Ihuman Historical Cash Flow
| IH Stock | USD 1.67 0.05 2.91% |
Analysis of Ihuman cash flow over time is an excellent tool to project Ihuman Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 304.3 M or Change In Working Capital of 24.3 M as it is a great indicator of Ihuman ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Ihuman Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ihuman Inc is a good buy for the upcoming year.
Ihuman |
About Ihuman Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Ihuman balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Ihuman's non-liquid assets can be easily converted into cash.
Ihuman Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Ihuman Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Ihuman operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Ihuman's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Ihuman Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Ihuman's Total Cash From Operating Activities is increasing as compared to previous years. The Ihuman's current Change To Account Receivables is estimated to increase to about 17.3 M, while Sale Purchase Of Stock is forecasted to increase to (8.2 M).
| 2021 | 2022 | 2024 | 2025 (projected) | Change To Liabilities | 43.4M | 69.8M | 80.2M | 84.2M | Change To Netincome | 38.6M | 41.8M | 37.7M | 71.0M |
Ihuman cash flow statement Correlations
Click cells to compare fundamentals
Ihuman Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ihuman cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 629.6M | (164K) | (47.7M) | (9.5M) | (8.6M) | (8.2M) | |
| Change To Inventory | 2.2M | (12.6M) | 46.0M | 3.0M | 3.5M | 3.3M | |
| Investments | (15.9M) | (32.0M) | (32.8M) | (6.5M) | (5.9M) | (6.2M) | |
| Change In Cash | 756.8M | (6.3M) | 1.3B | 163.8M | 188.3M | 178.9M | |
| Free Cash Flow | 207.1M | 5.9M | 1.2B | 165.6M | 190.5M | 304.3M | |
| Change In Working Capital | 165.0M | 30.2M | 178.0M | 22.2M | 25.5M | 24.3M | |
| Begin Period Cash Flow | 104.9M | 861.7M | 5.9B | 1.0B | 1.2B | 1.4B | |
| Total Cashflows From Investing Activities | (2.4M) | (15.9M) | (32.0M) | (32.8M) | (29.6M) | (28.1M) | |
| Other Cashflows From Financing Activities | 8.4M | 574K | 20.6K | 94K | 84.6K | 80.4K | |
| Depreciation | 2.8M | 6.4M | 74.2M | 11.7M | 13.4M | 17.6M | |
| Other Non Cash Items | 11.3M | 21.8M | 197.3M | (52.1M) | (59.9M) | (56.9M) | |
| Capital Expenditures | 15.9M | 32.3M | 45.1M | 6.5M | 7.5M | 7.1M | |
| Total Cash From Operating Activities | 223.0M | 38.2M | 1.3B | 172.1M | 197.9M | 323.2M | |
| Change To Account Receivables | (57.7M) | 21.6M | (195.3M) | 18.3M | 16.5M | 17.3M | |
| Change To Operating Activities | 3.8M | 12.5M | (22.1M) | (22.0M) | (19.8M) | (18.8M) | |
| Net Income | (37.5M) | (37.1M) | 752.5M | 180.9M | 208.0M | 218.4M | |
| Total Cash From Financing Activities | 572.0M | 410K | (47.7M) | (9.4M) | (8.5M) | (8.1M) | |
| End Period Cash Flow | 861.7M | 855.4M | 7.2B | 1.2B | 1.4B | 1.9B | |
| Change To Netincome | 270.8M | 92.6M | 38.6M | 41.8M | 37.7M | 71.0M | |
| Change To Liabilities | 40.8M | 208.0M | 43.4M | 69.8M | 80.2M | 84.2M | |
| Stock Based Compensation | 79.9M | 15.2M | 89.4M | 9.4M | 8.5M | 8.1M |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share 0.26 | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.